Could a common Anti-Inflammatory replace opioids after hip surgery?

NCT ID NCT07037888

Recruiting now Symptom relief Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests whether ketorolac, a non-opioid anti-inflammatory drug, can control pain after hip arthroscopy as well as or better than standard opioid medications. About 100 adults with femoroacetabular impingement undergoing hip arthroscopy will be randomly assigned to receive either ketorolac plus standard care or standard care alone. Researchers will measure pain levels and opioid use over the first few days after surgery, with follow-up up to 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ketorolac
What this could lead to: If successful, this could offer a safer, non-opioid option for managing pain after hip arthroscopy, reducing addiction risk and side effects.
What could go wrong: This is a small, single-center Phase 4 trial, so results may not apply broadly. Ketorolac may not control pain as effectively as opioids for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORACETABULAR IMPINGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoracetabular Impingement

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMORACETABULAR IMPINGEMENT HIP ARTHROSCOPY

Contacts and locations

Locations

Henry Ford Health
RECRUITING

Detroit, Michigan, 48202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.